# Juvena Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/juvena-therapeutics

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.juvenatherapeutics.com
- Total disclosed funding: $82M
- Latest round: Series B (Jun 27, 2025)
- Investors on record: 14

## About

Based in California, US, Juvena Therapeutics Inc. operates as a biotech firm that develops biologics for aging-related diseases. The company was founded by its CEO Hanadie Yousef, and CSO Jeremy O’Connell. In November 2022, Juvena Therapeutics Inc. raised USD 41 million in Series A funding, co-led by Horizons Ventures, Alumni Ventures Group, Bison Ventures, and Compound Ventures.

Juvena Therapeutics provides an artificial intelligence-based biologics drug development platform that is a machine learning-enabled platform for drug discovery and creates stem cell-secreted proteins and biologics for age- and chronic-related disorders. The company develops drugs through its pipeline project, JUV-161, which is a fusion protein therapeutic programme used for the treatment of neuromuscular diseases.

The company plans to use the funds raised in November 2022 to expand its manpower and strengthen its platform.

## Funding rounds

- Series B, Jun 27, 2025, $30M — Eli Lilly & Company, Mubadala Capital, Manta Ray Ventures, Bison Ventures, Jefferson Life Sciences
- Series A, May 16, 2022, $51M — Compound Ventures, Felicis Ventures, Horizons Ventures, Alumni Ventures Group, Plum Alley, Mubadala Capital, Manta Ray Ventures, BoxOne Ventures, Transform VC, Intersect VC, IRONGREY, Bison Ventures

## Investors

- Compound Ventures (https://capitalatlas.ai/funds/compound-ventures) — Series A
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series A
- Horizons Ventures — Series A
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series A
- Plum Alley (https://capitalatlas.ai/funds/plum-alley) — Series A
- Mubadala Capital (https://capitalatlas.ai/funds/mubadala-capital) — Series A, Series B
- Manta Ray Ventures (https://capitalatlas.ai/funds/manta-ray-ventures) — Series A, Series B
- BoxOne Ventures (https://capitalatlas.ai/funds/boxone-ventures) — Series A
- Transform VC (https://capitalatlas.ai/funds/transform-vc) — Series A
- Intersect VC (https://capitalatlas.ai/funds/intersect-vc) — Series A
- IRONGREY (https://capitalatlas.ai/funds/irongrey) — Series A
- Bison Ventures (https://capitalatlas.ai/funds/bison-ventures) — Series A, Series B
- Eli Lilly & Company — Series B
- Jefferson Life Sciences (https://capitalatlas.ai/funds/jefferson-life-sciences) — Series B